Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia.
about
C-terminal ADAMTS-18 fragment induces oxidative platelet fragmentation, dissolves platelet aggregates, and protects against carotid artery occlusion and cerebral strokeDC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by plateletsExpression of the 60 kDa and 71 kDa heat shock proteins and presence of antibodies against the 71 kDa heat shock protein in pediatric patients with immune thrombocytopenic purpuraImmune thrombocytopeniaPiecing together the humoral and cellular mechanisms of immune thrombocytopeniaRole of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopeniaThe initial inflammatory response to bioactive implants is characterized by NETosisThrombocytopenia and infections.Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia.Platelet fragmentation requires a specific structural conformation of human monoclonal antibody against beta3 integrin.Complement-independent Ab-induced peroxide lysis of platelets requires 12-lipoxygenase and a platelet NADPH oxidase pathway.Autoimmune thrombocytopenias.Thrombocytopenia in patients with severe acute respiratory syndrome (review).Platelet particle formation by anti GPIIIa49-66 Ab, Ca2+ ionophore A23187, and phorbol myristate acetate is induced by reactive oxygen species and inhibited by dexamethasone blockade of platelet phospholipase A2, 12-lipoxygenase, and NADPH oxidase.New insights into the mechanisms of nonimmune thrombocytopenia in neonates.Pathobiology of secondary immune thrombocytopenia.The ITP syndrome: pathogenic and clinical diversity.Dissolution of arterial platelet thrombi in vivo with a bifunctional platelet GPIIIa49-66 ligand which specifically targets the platelet thrombusSpecific cross-reaction of anti-dsDNA antibody with platelet integrin GPIIIa49-66A humanized single-chain variable fragment antibody against beta3 integrin in Escherichia coliHIV and SIV Associated Thrombocytopenia: An Expanding Role for Platelets in the Pathogenesis of HIV.A megakaryocyte with no platelets: anti-platelet antibodies, apoptosis, and platelet production.Role of CD61+ cells in thrombocytopenia of dengue patientsCrosstalk between Platelets and the Immune System: Old Systems with New DiscoveriesPathophysiology and management of primary immune thrombocytopenia.Contemporary treatment of immune thrombocytopenia.Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages.Integrin GPIIIa49-57 is the pivotal switch controlling platelet fragmentation.High levels of catalytic antibodies correlate with favorable outcome in sepsis.Dissolution of pre-existing platelet thrombus by synergistic administration of low concentrations of bifunctional antibodies against β3 integrin.IVIg treatment reduces catalytic antibody titers of renal transplanted patientsAutoantibodies with enzymatic properties in human autoimmune diseases.ADAMTS-18: a metalloproteinase with multiple functionsA humanized single-chain antibody against beta 3 integrin inhibits pulmonary metastasis by preferentially fragmenting activated platelets in the tumor microenvironment.Platelet receptor redox regulation.Immunomodulatory effects of intravenous immunoglobulins (IVIGs) in HIV-1 disease: a systematic review.Do proteolytic antibodies complete the panoply of the autoimmune response in acquired haemophilia A?Hematopoiesis and stem cell renewal in long-term bone marrow cultures containing catalase.Emerging Concepts in Immune Thrombocytopenia.Eptifibatide-Induced Profound Thrombocytopenia After Percutaneous Intervention for Acute Coronary Syndrome: A Challenging Clinical Scenario.
P2860
Q24310892-8155F25F-9B21-4EB0-821A-D198EA8C5CCFQ24673797-7BC7B434-D087-4483-8156-0D81E5C109B1Q24803680-345AD6ED-3784-4A56-85CB-6190E30C8BE0Q26830918-E43C56E7-DFEA-4C06-AC17-A9E2936940D7Q27024841-38850A3B-D102-4655-9E5D-29E21A54ACA1Q27488342-8A514376-F6D8-49D9-AE5F-1919D5B63FD2Q28390314-C9A148B4-D589-415B-BF16-A3833D350CB7Q30240119-1DF65147-1B88-40A7-8A0E-5068BBA9CF64Q31154319-9483DF09-E571-40C5-B6E8-C8C016B071FCQ33308465-8CBFB998-AAFF-4CCC-AB85-D04EB74EDC96Q33360225-7CE1F163-0231-4544-BEC1-6C39E9F66151Q33363539-E4EC949C-733F-4329-922A-0EECA09832FAQ33367297-36811017-4855-4E2D-9BEC-368210843A31Q33375459-5EF16D0C-A572-427B-A1C5-C4EAFDE20D76Q33382906-B1BFCCE0-7A47-496B-B803-8EDF74D16C9DQ33383468-31E95B21-D76F-4DFC-839F-C9E5DB22A2FDQ33384235-6F6068DE-B56C-4EFE-86D9-4A9838FCAA00Q33389941-4DE72862-23A2-4CE8-813E-88497EE2FC48Q33391806-8BD179D9-3463-4694-AF46-279222894E0DQ33398622-61F08099-3DD5-42F8-8256-86D04B4F1C09Q33401168-BA52E76A-8C15-40B2-8281-E06B51F99796Q33402025-1CA60C4C-27CF-4888-9511-A16BD2E0200DQ33403375-EB480F7E-B5CC-4F4E-B3C4-5100F52E2D8EQ33403517-660D0229-CA73-4634-BB74-22D31747D738Q33407942-47A424AD-45D4-4CAE-90DF-3C53268CA2D8Q33410653-60771D67-4B97-4212-990F-642E8C7D3CABQ33411216-9203FB53-4ED9-4B10-A9D5-EFF518BCDEBEQ33421433-223DF4D8-062B-4099-8F62-B1A91B3DFA93Q33932633-2BE82535-0476-4564-9211-F60E44919382Q34064897-6266350C-ABF3-45D8-98F5-3C387DC7096EQ34962680-C3416C30-3318-4A18-A221-02B93DF4A51FQ35214200-90CB98CA-A029-43D7-B1FE-EA8FCABAEDB7Q35541843-B5977D5B-C97A-4831-ABB6-B929E6356628Q36305346-59CC4511-0A9E-42D8-A2FB-560E64D5DA84Q37071700-DE832325-0AC2-4113-936B-E10149B46947Q37822450-77ADF192-E769-4AAB-ABB5-03D1E35E7A6EQ37944291-9A361678-832D-40F9-99FD-86E9622BDE86Q41998583-20D8A5F4-5A8F-4D27-AC58-4D1512E28D40Q54211951-1A1E663D-4CBB-4ECB-9DC9-261132EA0883Q55339070-ACA952C2-A481-4E34-88BF-330B817B787F
P2860
Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Complement-independent, peroxi ...... lated immune thrombocytopenia.
@ast
Complement-independent, peroxi ...... lated immune thrombocytopenia.
@en
Complement-independent, peroxi ...... lated immune thrombocytopenia.
@nl
type
label
Complement-independent, peroxi ...... lated immune thrombocytopenia.
@ast
Complement-independent, peroxi ...... lated immune thrombocytopenia.
@en
Complement-independent, peroxi ...... lated immune thrombocytopenia.
@nl
prefLabel
Complement-independent, peroxi ...... lated immune thrombocytopenia.
@ast
Complement-independent, peroxi ...... lated immune thrombocytopenia.
@en
Complement-independent, peroxi ...... lated immune thrombocytopenia.
@nl
P2093
P1433
P1476
Complement-independent, peroxi ...... lated immune thrombocytopenia.
@en
P2093
Karpatkin S
Tomlinson S
P304
P356
10.1016/S0092-8674(01)00477-9
P407
P577
2001-09-01T00:00:00Z